comparemela.com

Promis Neurosciences Doses First Subjects In Phase 1A Clinical Trial Of PMN310 To Treat Alzheimer'S Disease

Promis Neurosciences Doses First Subjects In Phase 1A Clinical Trial Of PMN310 To Treat Alzheimer'S Disease

menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States ,Toronto ,Ontario ,Canada , ,Exchange Commission ,Promis Neurosciences Inc ,Nasdaq ,Gail Farfel ,Chief Executive Officer ,Mild Cognitive Impairment ,Clinical Trial ,Single Ascending Dose Study ,Healthy Volunteers ,Collective Coordinates ,Disease Specific Epitopes ,Private Securities Litigation Reform Act ,Annual Report ,Post Effective Amendment ,Investor Relations ,Marie Field ,

comparemela.com © 2020. All Rights Reserved.